| OPTHEA LTD (SP.ADR/8) |
| USA |
| Gesundheit |
| US68386J2087 / A2QEW7 |
| UKJ2 (Frankfurt) |
| FRA:UKJ2, ETR:UKJ2, UKJ2:GR |
| - |
| https://opthea.com/ |
|
Opthea Ltd Sponsored ADR is an American Depositary Receipt representing shares of Opthea Limited, an Australian-based biotechnology company. The primary function of this financial instrument is to offer U.S. investors easier access to Opthea Limited'..
>Volltext.. |
| 437.59 Mio. EUR |
| 418.65 Mio. EUR |
| - |
| - |
| 164.29 Mio. EUR |
| 0.97 EUR |
| - |
| 18.94 Mio. EUR |
| -79.56 Mio. EUR |
| 18.21 |
| -98.11% |
| - |
| - |
| - |
| - |
| - |
| OPTHEA ADR, OPTHEA |
| 08.04.26 |
|